361 related articles for article (PubMed ID: 31397998)
21. A versatile supramolecular nanoagent for three-pronged boosting chemodynamic therapy.
Liu X; Liu J; Xu Q; Tao W; Xie X; Meng C; Zhou Q; Zhang Y; Ling Y
J Colloid Interface Sci; 2023 Oct; 648():994-1005. PubMed ID: 37331080
[TBL] [Abstract][Full Text] [Related]
22. Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells.
Chen C; Tan Y; Xu T; Sun Y; Zhao S; Ouyang Y; Chen Y; He L; Liu X; Liu H
Langmuir; 2022 Oct; 38(40):12307-12315. PubMed ID: 36154182
[TBL] [Abstract][Full Text] [Related]
23. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
24. Eradication of solid tumors by chemodynamic theranostics with H
Wang N; Zeng Q; Zhang R; Xing D; Zhang T
Theranostics; 2021; 11(5):2334-2348. PubMed ID: 33500728
[TBL] [Abstract][Full Text] [Related]
25. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
[TBL] [Abstract][Full Text] [Related]
26. A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H
Zhu XY; Wang TY; Jia HR; Wu SY; Gao CZ; Li YH; Zhang X; Shan BH; Wu FG
J Control Release; 2024 Mar; 367():892-904. PubMed ID: 38278369
[TBL] [Abstract][Full Text] [Related]
27. A Novel Polyamino Acid Sulfur Dioxide Prodrug Synergistically Elevates ROS with β-Lapachone in Cancer Treatment.
Tang B; Zhang Y; Liu X; Wang Y; He P
J Pharm Sci; 2024 May; 113(5):1239-1247. PubMed ID: 38042342
[TBL] [Abstract][Full Text] [Related]
28. pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers.
Ji M; Liu H; Wang H; Liang X; Wei M; Shi D; Gou J; Yin T; He H; Tang X; Zhang Y
Biomater Sci; 2023 Sep; 11(18):6267-6279. PubMed ID: 37545202
[TBL] [Abstract][Full Text] [Related]
29. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor.
Zhang Y; Hu H; Deng X; Song Q; Xing X; Liu W; Zhang Y
Int J Nanomedicine; 2022; 17():5491-5510. PubMed ID: 36438608
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable BiOCl platform for oxidative stress injury-enhanced chemodynamic/radiation therapy of hypoxic tumors.
Liu Y; Zhang J; Du J; Song K; Liu J; Wang X; Li B; Ouyang R; Miao Y; Sun Y; Li Y
Acta Biomater; 2021 Jul; 129():280-292. PubMed ID: 34033970
[TBL] [Abstract][Full Text] [Related]
31. Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy.
Dong Z; Feng L; Chao Y; Hao Y; Chen M; Gong F; Han X; Zhang R; Cheng L; Liu Z
Nano Lett; 2019 Feb; 19(2):805-815. PubMed ID: 30592897
[TBL] [Abstract][Full Text] [Related]
32. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
Acta Biomater; 2024 May; ():. PubMed ID: 38801869
[TBL] [Abstract][Full Text] [Related]
33. Fe
Chen T; Chu Q; Li M; Han G; Li X
J Nanobiotechnology; 2021 Jul; 19(1):206. PubMed ID: 34246260
[TBL] [Abstract][Full Text] [Related]
34. Advanced biomimetic nanoreactor for specifically killing tumor cells through multi-enzyme cascade.
Liu W; Wu J; Ji X; Ma Y; Liu L; Zong X; Yang H; Dai J; Chen X; Xue W
Theranostics; 2020; 10(14):6245-6260. PubMed ID: 32483451
[TBL] [Abstract][Full Text] [Related]
35. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
[TBL] [Abstract][Full Text] [Related]
36. H
Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
[TBL] [Abstract][Full Text] [Related]
37. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
[TBL] [Abstract][Full Text] [Related]
38. Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents.
Kwon B; Han E; Yang W; Cho W; Yoo W; Hwang J; Kwon BM; Lee D
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5887-97. PubMed ID: 26888039
[TBL] [Abstract][Full Text] [Related]
39. Copper(II)-based metal-organic framework delivery of calcium ascorbate for enhanced chemodynamic therapy
Zhang M; Xue H; Yang J; Zhao X; Xue M; Sun W; Qiu J; Zhu Z
Biomater Sci; 2024 Mar; 12(7):1871-1882. PubMed ID: 38411574
[TBL] [Abstract][Full Text] [Related]
40. A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H
Liu M; Xu H; Zhou F; Gong X; Tan S; He Y
J Mater Chem B; 2023 Nov; 11(45):10822-10835. PubMed ID: 37920970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
